Product news

Cephalon has received FDA approval for Treanda (bendamustine hydrochloride), an injectable indicated for the treatment of patients with indolent B-cell non-Hodgkin's lymphoma.
You must be a registered member of MMM to post a comment.
 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.